OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-“Chemobrain”
Amelia Maria Găman, Adriana Uzoni, Aurel Popa‐Wagner, et al.
Aging and Disease (2016) Vol. 7, Iss. 3, pp. 307-307
Open Access | Times Cited: 99

Showing 51-75 of 99 citing articles:

The Involvement of Oxidative Stress in Chronic Myeloid Leukemia
Emilia Georgiana Pascu, Mihnea‐Alexandru Găman, Cornel Moisă, et al.
ROMANIAN BIOTECHNOLOGICAL LETTERS (2020) Vol. 25, Iss. 1, pp. 1267-1274
Open Access | Times Cited: 10

Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon
Muhammad Torequl Islam, Eunüs S. Ali, Ishaq N. Khan, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 20, Iss. 14, pp. 1636-1647
Closed Access | Times Cited: 10

Peptides Derived from Angiogenin Regulate Cellular Copper Uptake
Giovanni Tabbı̀, Lorena Maria Cucci, Calogero Pinzino, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9530-9530
Open Access | Times Cited: 9

Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice
Yang Liu, Steve Reiken, Haikel Dridi, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Closed Access | Times Cited: 3

Effects of chemotherapy for acute lymphoblastic leukemia on cognitive function in animal models of contemporary protocols: A systematic literature review
Tyler Alexander, Kevin R. Krull
Neuroscience & Biobehavioral Reviews (2021) Vol. 129, pp. 206-217
Open Access | Times Cited: 6

Chemotherapy-Induced Cognitive Decline: Moving from the Mechanistic Debate towards Prevention and Treatment—A Clinical Review
Roi Tschernichovsky, Lauren Philp, Annekathryn Goodman
Journal of Cancer Therapy (2019) Vol. 10, Iss. 12, pp. 985-1012
Open Access | Times Cited: 5

Cognitive Perception among Post-Chemotherapy, Non-Chemotherapy Breast Cancer Survivors and Non-Cancer
Hilman Syarif, Agung Waluyo, Yati Afiyanti
Asian Pacific Journal of Cancer Prevention (2021) Vol. 22, Iss. 6, pp. 1775-1780
Open Access | Times Cited: 5

Neurological complications of systemic cancer and antineoplastic therapy
Gilbert Youssef, Patrick Y. Wen, Eudocia Q. Lee
Elsevier eBooks (2022), pp. 479-500
Closed Access | Times Cited: 3

Oxidase Reactivity of CuII Bound to N-Truncated Aβ Peptides Promoted by Dopamine
Chiara Bacchella, Simone Dell’Acqua, Stefania Nicolis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5190-5190
Open Access | Times Cited: 4

Unveiling the neuroprotective potential of chrysin on the pre-frontal cortex of adult male Wistar rats
Ifeanyi Anthony Egwuatu, Chiadikobi Lawrence Ozoemena, Fortune Kasiemobi Onuorah
Deleted Journal (2024) Vol. 1, pp. 62-68
Closed Access

Potential Pathways for Chemotherapy-Induced Cognitive Decline
Mini Dahiya, Monu Yadav, Pratibha Sharma, et al.
(2024), pp. 1177-1194
Closed Access

Improving Cognitive Safety in High-Risk Patients: A Cognitive Assessment-based Approach
Mark Chignell, Alyssa Iglar, Megan Singh, et al.
Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care (2024) Vol. 13, Iss. 1, pp. 78-83
Closed Access

Diagnostic and Treatment Approaches to Chemo Brain
Fatma Gül Helvacı Çelik, Meltem Puşuroğlu, Sefanur Köse, et al.
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2024) Vol. 17, Iss. 2, pp. 301-322
Open Access

Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis
Fatma G Aboelnasr, Mina Y. George, Maha Nasr, et al.
European Journal of Pharmacology (2024), pp. 177217-177217
Closed Access

Chemo brain: myth or clinical reality? Literature review and clinical case
К. К. Yakhin, Dina T. Zagretdinova, Konstantin S. Sergienko
Neurology Bulletin (2024) Vol. LVI, Iss. 4, pp. 426-438
Open Access

Neurological complications of systemic tumor therapy
Wolfgang Grisold, Wolfgang N. Löscher, Anna Grisold
Wiener Medizinische Wochenschrift (2018) Vol. 169, Iss. 1-2, pp. 33-40
Closed Access | Times Cited: 3

The Mechanism of Chemotherapy Toxicity to the Hippocampus and its Intervention Measures
Yue Yang, Shuhan Zhang
Highlights in Science Engineering and Technology (2024) Vol. 99, pp. 147-151
Open Access

Synergistic Effects of Metformin and Fluorouracil on Cognitive Disability via Inducing Neuroinflammation in Rat Models
Ahmad Alhowail
International Journal of Pharmacology (2024) Vol. 20, Iss. 8, pp. 1421-1431
Closed Access

Nigella sativa oil alleviates doxorubicin-induced cardiomyopathy and neurobehavioral changes in mice: In vivo and in-silico study
Md Jamir Anwar, Sattam Khulaif Alenezi, Faizul Azam, et al.
Asian Pacific Journal of Tropical Biomedicine (2022) Vol. 12, Iss. 7, pp. 312-322
Open Access | Times Cited: 2

Neuropsychology of Chemotherapy in Brain Tumor Patients
Ashlee R. Loughan, Deborah Allen, Diane Von Ah, et al.
Elsevier eBooks (2018), pp. 783-809
Closed Access | Times Cited: 1

Exercise oncology. From theory to the practice
Soraya Casla-Barrio, Jordi Alfaro-Gamero
DOAJ (DOAJ: Directory of Open Access Journals) (2018)
Open Access | Times Cited: 1

Scroll to top